Commodities boom prompts some profit-taking
The price of copper and gold have been boosted by bullish short-term sentiment, but as always I believe investors should also continue to take a long-term view.
Independent. Trusted. Proven.
Browse current and previous editions of Switzer Report
The price of copper and gold have been boosted by bullish short-term sentiment, but as always I believe investors should also continue to take a long-term view.
With the market increasingly pricing in a February RBA rate rise, investors are facing a very different setup to the one they expected just weeks ago.
For market players, 2026 (just like 2025) is set to be the same as it was overnight — Trump-v-the economy, with AI remaining both the pumper of stock prices, as well as the potential thumper, if it underperforms in reporting season.
Lithium prices have been rising since mid-2025, but the surge of the white metal into 2026 has been remarkable. Here are three opportunities that might look appealing to some investors.
Here are two US small-cap ETFs that provide exposure to stronger US economy this year.
Why has Amcor’s share price jumped? How safe is Australian Military Bank, which is paying 4.7% for a 10 month term deposit? What does Deterra Royalties do? Are there any ETFs that invest in mining companies?
In our “HOT” stock article, Michael Gable, Managing Director of Fairmont Equities, explains why at current levels New Hope Corporation Ltd (NHC) presents a buying opportunity.
In this week’s episode of Boom Doom Zoom, Paul Rickard and Peter Switzer work through a market that looks calm on the surface, but uneasy underneath.
While CSL has become a real head scratcher, a fall in its share price is understandable. But has the fall been excessive? Its sell off looks way over the top.
Although I’ve never been a gold bug, I have been investing in gold over the last few months. Let me explain how I invest in gold.
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk explains why the Morgan’s team maintains a buy rating on Amcor (AMC).
Here are four biotech ETFs for long-term contrarian investors to consider.
Every investor is looking for meaningful capital gain when they buy a stock. Here are two candidates that look capable of delivering that in 2026.
For the week ending Friday 16 January 2026, FNArena registered no less than 15 upgrades in ratings for ASX-listed stocks.
On this kick-off ep for the new year, we're looking at roughed-up companies on the market that might be worth a second look. Quality stocks are being sold hard, resources are back in favour, and investors are asking the same uncomfortable question, is this a buying opportunity or a value trap?
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.